Flovent Rotadisk
Company: GlaxoSmithKlineApproval Status: Approved November 1997
Treatment for: asthma
Areas: Pediatrics; Respiratory
General Information
Flovent Rotadisk, a fluticasone inhalation powder, has been approved for the maintenance treatment of asthma in patients four and older. The corticosteroid is dosed twice daily and is available in strengths of 50 mcg and 100 mcg for children and adults and in a 250 mcg for adults.
Flovent Rotadisk Drug Information
The Flovent Rotadisk drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
